R. Loch Macdonald
2017
In 2017, R. Loch Macdonald earned a total compensation of $1.3M as Chief Scientific Officer at Edge Therapeutics, a 32% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $153,765 |
|---|---|
| Option Awards | $724,493 |
| Salary | $402,000 |
| Other | $10,800 |
| Total | $1,291,058 |
Macdonald received $724.5K in option awards, accounting for 56% of the total pay in 2017.
Macdonald also received $153.8K in non-equity incentive plan, $402K in salary and $10.8K in other compensation.
Rankings
In 2017, R. Loch Macdonald's compensation ranked 7,749th out of 14,666 executives tracked by ExecPay. In other words, Macdonald earned more than 47.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,749 out of 14,666 | 47th |
Division Manufacturing | 2,904 out of 5,768 | 50th |
Major group Chemicals And Allied Products | 943 out of 2,074 | 55th |
Industry group Drugs | 730 out of 1,730 | 58th |
Industry Pharmaceutical Preparations | 569 out of 1,329 | 57th |
Source: SEC filing on April 25, 2018.
Macdonald's colleagues
We found four more compensation records of executives who worked with R. Loch Macdonald at Edge Therapeutics in 2017.